MAPK7 and neoplasm: In addition, other studies mainly carried out in tumor cell lines have shown that a reduction in the levels of ERK5 or its pharmacological targeting decreased the proliferation of a number of cell lines or even caused cell death, raising the possibility that targeting of that pathway could be used for therapeutic purposes3.